Free tool
FAERS Monitor: Nexterone
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 022325 or its brand name (Nexterone, Amiodarone Hydrochloride). Reports on generic versions are filed under their own applications.
Reports
9,437
Serious
8,191
87% of reports
Hospitalization
4,651
Death reported
1,606
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- dyspnoea1,008
- off label use869
- asthenia837
- fatigue779
- drug ineffective712
- product use in unapproved indication648
- nausea548
- cough532
- atrial fibrillation476
- dizziness476
- drug interaction454
- pneumonia452
- vomiting440
- hypotension431
- condition aggravated411
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 59 |
| 2005 | 106 |
| 2006 | 83 |
| 2007 | 68 |
| 2008 | 41 |
| 2009 | 108 |
| 2010 | 119 |
| 2011 | 140 |
| 2012 | 338 |
| 2013 | 144 |
| 2014 | 149 |
| 2015 | 187 |
| 2016 | 218 |
| 2017 | 504 |
| 2018 | 500 |
| 2019 | 619 |
| 2020 | 605 |
| 2021 | 843 |
| 2022 | 940 |
| 2023 | 941 |
| 2024 | 1,058 |
| 2025 | 1,049 |
| 2026 | 616 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,044,722 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| atrial fibrillationSignal | 476 | 10.9 | 10.0 | 4,289 |
| drug interactionSignal | 454 | 6.4 | 5.8 | 2,070 |
| product use in unapproved indicationSignal | 648 | 5.8 | 5.4 | 2,619 |
| astheniaSignal | 837 | 5.0 | 4.7 | 2,693 |
| hypotensionSignal | 431 | 4.8 | 4.4 | 1,301 |
| coughSignal | 532 | 4.2 | 3.9 | 1,326 |
| dyspnoeaSignal | 1,008 | 4.0 | 3.7 | 2,298 |
| pneumoniaSignal | 452 | 3.1 | 2.8 | 656 |
| condition aggravatedSignal | 411 | 3.0 | 2.7 | 559 |
| fatigueSignal | 779 | 2.2 | 2.1 | 548 |
| off label useSignal | 869 | 2.2 | 2.1 | 601 |
| dizzinessSignal | 476 | 2.1 | 1.9 | 290 |
| vomitingSignal | 440 | 2.1 | 1.9 | 253 |
| nausea | 548 | 1.5 | 1.4 | 108 |
| drug ineffective | 712 | 1.2 | 1.1 | 26 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.